Abramson Cancer Center
Philadelphia, Pennsylvania 19104
7 studies enrolling now · 30 studies all time
What they study most
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult Nodular Sclerosis Hodgkin Lymphoma, Advanced Solid Tumors, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma
Studies at this site
- WBSI Guided Personalized Delivery of TTFields — Recruiting now
- Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) — Recruiting now
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
- Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support — Recruiting now
- Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction — Recruiting now
- Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma — Recruiting now
- Role of the Immune Environment in Response to Therapy in Breast Cancer — Recruiting now
- A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) — Running, not enrolling
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation — Running, not enrolling
- Evaluating Cascade Communication Methods — Completed
- Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
- DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] — Completed
- HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis — Running, not enrolling
- Behavioral Economic Strategies to Improve PRO Adherence — Completed
- A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer — Completed
- Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer — Running, not enrolling
- An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma — Completed
- A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody — Running, not enrolling
- FITBIT Study on Mobility and Readmissions After Radical Cystectomy — Completed
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors — Status unconfirmed
- 'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers — Completed
- A Safety and Efficacy Study in Patients With Gastric Cancer — Completed
- My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors — Completed
- TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC) — Stopped early
- CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma — Completed
- Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy — Completed
- Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
- Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) — Completed
- BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus — Completed
- Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma — Stopped early